Research group Clinical neuroscience in psychiatry

Aims

• The influence of stress on the brain as measured by cognition an neuroimaging in health and disease-Gene-by-environment interactions to determine depressive vulnerability in the form of memory bias.
• The relationship between physical and neurocognitive complaints in observational cohorts.
• The neurocognitive prevention and in particular neuromodulation treatment of stress-related mental disorders-Personalizing vulnerability staging in care programmes.
• Extending the primary and secondary prevention part with the life span perspective, understanding the long-term consequences of stress during early development.
• Investigate the mechanistic underpinnings and clinical effectivity of magnetic seizure therapy.
• Continue multicenter clinical trials with non-invasive neuromodulation whereby I am to focus also more on the aspect of relapse prevention and the potential of transdiagnostic application. This will create innovate treatment options which can then be implemented in care.
• Include aspect of promoting resilience by augmenting positive schema memory as prevention topic in my cohort work and line up with initiatives of the prevention and AI tile of the sector plan.

Publications

See the publication list of the research group leader on Web of Science.